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Abstract 
 
Stress plays a role in the development and severity of psychotic symptoms and there may be 
a genetic component to stress vulnerability in schizophrenia. Using an established mouse 
model for schizophrenia, we investigated the behavioural and endocrine response of Nrg1 
transmembrane domain mutant mice (Nrg1 HET) and wild type-like (WT) littermates to acute 
restraint stress. Animals were screened at 3–4 months and 6–7 months of age (before and 
after onset of hyperlocomotion) for open field behaviour and serum corticosterone levels. In 
younger mice, stress reduced locomotive and explorative measures and increased anxiety-
like behaviour regardless of genotype. Older Nrg1 mutants were less susceptible to the 
effects of stress on anxiety-related behaviours. All mice responded to restraint stress with 
robust increases in serum corticosterone. Importantly, the stress-induced increase in 
corticosterone was more pronounced in Nrg1 mutant than WT mice at the younger but not the 
older age. Our results suggest that transmembrane domain Nrg1 has only a moderate effect 
on the acute stress response of mice. The behavioural differences detected between WT and 
Nrg1 HET mice at the older age were evident without parallel modifications to the 
glucocorticoid system.	  	  
1. Introduction 	  
Neuregulin 1 (NRG1) has been associated with an increased risk to develop schizophrenia ( 
[27] and [35]; meta-analyses: [23], [26] and [30]). The protein is involved in axon guidance, 
myelination, and synapse formation. Alternative promoter usage results in numerous splice 
variant types and more than 30 isoforms [11] and [21]. The isoform variants most commonly 
expressed in the brain contain a transmembrane domain [10], [11] and [35]. 
 Studies suggest stress plays a role in the development and severity of psychotic 
symptoms. Indeed, stress can precipitate symptom onset [7] and trigger relapse in 
schizophrenia patients [13]. Importantly, there may be a genetic component to stress 
vulnerability in schizophrenia, because (1) schizophrenia patients handle negative life events 
more poorly than healthy subjects [12] and have an underlying vulnerability to stress [34], (2) 
first degree relatives of schizophrenia patients demonstrate increased stress sensitivity [24], 
and (3) a NRG1 polymorphism interacts with psychosocial stress to affect reactivity to 
expressed emotions [18]. 
 The heterozygous Nrg1 transmembrane domain mutant mouse (Nrg1 HET) is an 
animal model of schizophrenia providing face, construct and predictive validity. Nrg1 HETs 
display an age-dependent hyperactivity (reversible by clozapine [15] and [27]). Additionally, 
mutant mice exhibit an anxiolytic-like and cognitive phenotype [6], [9] and [15]. Interestingly, 
Nrg1 modulates the effects of the psychoactive cannabis constituent Δ9-tetrahydrocannabinol 
on stress-related brain circuitry in mice [3] and [4] and is expressed in brain regions 
controlling stress reactivity [5]. Furthermore, observations from animal caretakers suggest 
that Nrg1 mutant mice are more susceptible to transport stress. 
 The current study aimed to evaluate the behavioural and endocrine (i.e. serum 
corticosterone) response of Nrg1 mutants and WT littermates to acute restraint stress. Test 
animals were screened before and after onset of the schizophrenia-relevant hyperlocomotive 
phenotype for baseline and stress-induced open field behaviour. This paradigm has produced 
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the most consistent schizophrenia-relevant Nrg1 phenotype in the past and enables the 
analysis of anxiety-related behaviours [15]. 
  
 
2. Material and methods 
 
2.1. Animals 
Test animals were male Nrg1 HET and WT littermates (C57BL6/JArc background) [27], as 
they have shown more pronounced phenotypes than females [4], [6], [9] and [20]. Age-
matched test mice (±7 days) were used at the age of 3–4 months (8 Nrg1 HETs, 11 WTs) and 
the age of 6–7 months (10 Nrg1 HETs, 17 WTs). Test mice were pair-housed in cages 
equipped with an igloo (Bioserv, Frenchtown, USA) and a metal ring (3 cm diameter) in the 
cage lid. Mice were kept under a 12:12 h light:dark schedule (red light permanently present: 
illumination < 5 lx). Research and animal care procedures were approved by the University of 
New South Wales Animal Care and Ethics Committee and were in accordance with the EC 
Directive 86/609/EEC for animal experiments. 
 
2.2. Open field (OF) 
Baseline OF testing was conducted to confirm the age-dependent hyperlocomotive 
phenotype of Nrg1 mutants [15], [16] and [17]. The response to restraint stress was 
investigated after an inter-test interval of at least seven days. Mice were placed in OF activity 
chambers (Med Associates Inc., St Albans, USA) for 30 min. Distance travelled and vertical 
activity (as an indirect measure of rearing) as well as resting in central and peripheral zones 
was recorded [15] and [16]. The ratio of the distance travelled in the center relative to the total 
distance travelled (‘distance ratio’) and the time spent in the center (‘center time’) were taken 
as measures of anxiety [8]. 
 
2.3. Corticosterone analysis 
Mice were taken from the home cage 60 min after onset of the light phase and placed in 
restraint tubes for 15 min (Broome Rodent Restrainer: Harvard Apparatus, Holliston, USA). 
Following a 5 min recovery period, mice were tested in the OF. Blood samples were taken 
prior to and following restraint stress within 3 min from the tail vein. Samples were stored on 
ice until centrifugation (13,000 rpm for 5 min). Serum corticosterone was analysed using a 
radioimmunoassay kit from ICN Biomedicals (Costa Mesa, USA) [25]. 
 
2.4. Statistical analysis 
Results were analysed as published previously [15] and [16] by three-way repeated measures 
(RM) analysis of variance (ANOVA) using the within factor ‘restraint stress’ and ‘age’ and the 
between factor ‘genotype’. This was followed by lower-degree ANOVAs (i.e. two-way and 
one-way ANOVAs) split by corresponding factors where appropriate. One-way ANOVAs were 
also chosen for Δ (Restraint–Baseline). Analyses were conducted using Statview Version 5.0. 
Differences were regarded as statistically significant if p < .05. All data are presented as 
means ± standard error of the mean (SEM) or Δ mean (Restraint–Baseline). 
 
3. Results 
 
3.1. Open field behaviour 
Nrg1 mutant mice exhibited hyperlocomotion compared to WT mice (p = .001). However, 
looking at age effects separately, OF locomotion was only significantly different between Nrg1 
HET mice and WT littermates at the age of 6–7 months (p = .003; Fig. 1B), whereas total 
distance travelled of young Nrg1 HET mice was not significantly increased (p > .05; Fig. 1A). 
Exposure to acute stress had no significant impact on the hyperlocomotive phenotype of older 
Nrg1 mutant mice (no interaction of ‘restraint stress’ with ‘genotype’). Furthermore, ‘genotype’ 
had an impact on resting time (p = .03) and distance travelled in the periphery (p = .003). 
Two-way ANOVAs for the older cohort revealed that mutants exhibited a decrease in resting 
time (p = .02; significant at baseline) and increase in locomotion in the periphery (p = .02; 
significant post restraint stress) compared to WTs (Table 1). 
Chesworth	  et	  al.	  /	  Neuroscience	  Letters	  515(1):	  82-­‐86,	  2012	  
	  
	  	  	   	  
R. Chesworth et al. / Neuroscience Letters 515 (2012) 82– 86 83
2. Material and methods
2.1. Animals
Test animals were male Nrg1 HET and WT  littermates
(C57BL6/JArc background) [27], as they have shown more pro-
nounced phenotypes than females [4,6,9,20]. Age-matched test
mice (±7 days) were used at the age of 3–4 months (8 Nrg1 HETs,
11 WTs) and the age of 6–7 months (10 Nrg1 HETs, 17 WTs). Test
mice were pair-housed in cages equipped with an igloo (Bioserv,
Frenchtown, USA) and a metal ring (3 cm diameter) in the cage lid.
Mice were kept under a 12:12 h light:dark schedule (red light per-
manently present: illumination < 5 lx). Research and animal care
procedures were approved by the University of New South Wales
Animal Care and Ethics Committee and were in accordance with
the EC Directive 86/609/EEC for animal experiments.
2.2. Open field (OF)
Baseline OF testing was conducted to confirm the age-
dependent hyperlocomotive phenotype of Nrg1 mutants [15–17].
The response to restraint stress was investigated after an inter-
test interval of at least seven days. Mice were placed in OF activity
chambers (Med Associates Inc., St Albans, USA) for 30 min. Distance
travelled and vertical activity (as an indirect measure of rearing) as
well as resting in central and peripheral zones was recorded [15,16].
The ratio of the distance travelled in the center relative to the total
distance travelled (‘distance ratio’) and the time spent in the center
(‘center time’) were taken as measures of anxiety [8].
2.3. Corticosterone analysis
Mice were taken from the home cage 60 min  after onset of
the light phase and placed in restraint tubes for 15 min  (Broome
Rodent Restrainer: Harvard Apparatus, Holliston, USA). Following
a 5 min  recovery period, mice were tested in the OF. Blood sam-
ples were taken prior to and following restraint stress within 3 min
from the tail vein. Samples were stored on ice until centrifugation
(13,000 rpm for 5 min). Serum corticosterone was analysed using
a radioimmunoassay kit from ICN Biomedicals (Costa Mesa, USA)
[25].
2.4. Statistical analysis
Results were analysed as published previously [15,16] by
three-way repeated measures (RM) analysis of variance (ANOVA)
using the within factor ‘restraint stress’ and ‘age’ and the
between factor ‘genotype’. This was followed by lower-degree
ANOVAs (i.e. two-way and one-way ANOVAs) split by corre-
sponding factors where appropriate. One-way ANOVAs were
also chosen for ! (Restraint–Baseline). Analyses were con-
ducted using Statview Version 5.0. Differences were regarded
as statistically significant if p < .05. All data are presented
as means ± standard error of the mean (SEM) or ! mean
(Restraint–Baseline).
3. Results
3.1. Open field behaviour
Nrg1 mutant mice exhibited hyperlocomotion compared to WT
mice (p = .001). However, looking at age effects separately, OF loco-
motion was only significantly different between Nrg1 HET mice and
WT  littermates at the age of 6–7 months (p = .003; Fig. 1B), whereas
total distance travelled of young Nrg1 HET mice was not signifi-
cantly increased (p > .05; Fig. 1A). Exposure to acute stress had no
Fig. 1. Open field locomotion. Total distance travelled [cm] is shown in (A) 3–4-
month old mice and (B) 6–7-month old mice at baseline and following acute restraint
stress. Significant one-way ANOVA effects of stress versus baseline of the corre-
sponding genotype are indicated by ‘#’ (#p < .05, ##p < .01) whereas significant effects
of  Nrg1 versus WT mice of the corresponding stress group are indicated by asterisks
(*p  < .05).
significant impact on the hyperlocomotive phenotype of older Nrg1
mutant mice (no interaction of ‘restraint stress’ with ‘genotype’).
Furthermore, ‘genotype’ had an impact on resting time (p = .03) and
distance travelled in the periphery (p = .003). Two-way ANOVAs for
the older cohort revealed that mutants exhibited a decrease in rest-
ing time (p = .02; significant at baseline) and increase in locomotion
in the periphery (p = .02; significant post restraint stress) compared
to WTs  (Table 1).
Acute restraint stress had a significant impact on the
behavioural performance of mice. Stress inhibited locomotive and
explorative behaviours and increased resting time. Three-way
ANOVAs detected an overall effect of stress on total distance trav-
elled (p < .001), distance travelled in the periphery (p < .001), rearing
frequency (p < .001), and resting time (p = .001) (Fig. 1 and Table 1).
This impact of stress on OF behaviour was evident in both test
cohorts: mice at the age of 3–4 months showed a significant stress
response in total and peripheral distance travelled (both p < .001),
frequency of rearing (p = .002) and resting time (p < .001) (Fig. 1A
and Table 1). Similarly, mice in the 6–7 month old test group
exhibited stress-induced changes to distance travelled (p = .003),
distance travelled in the periphery (p = .003), frequency of rearing
(p < .001), and resting time (p = .004) (Fig. 1B and Table 1).
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Table 1
Effect of restraint stress on open field behaviours in Nrg1 HET and WT mice. Data for distance travelled in periphery (PerDistance), rearing frequency, time spent resting (i.e.
RestTime), and time in the center of the OF (CenterTi e) re presented as means ± SEM.
Baseline Restraint stress ! (Restraint − Baseline)
WT  Nrg1 HET WT  Nrg1 HET WT  Nrg1 HET
3–4-month old mice
PerDistance [cm] 2264.4 ± 133.7 2808.7 ± 279.4 1825.2 ± 114.9## 2320.1 ± 292.1# −439.2 ± 130.6 −488.6 ± 175.0
Rearing  [n] 218.8 ± 23.1 303.6 ± 52.9 174.9 ± 19.2 215.0 ± 25.2# −43.9 ± 21.0 −88.6 ± 32.6
RestTime [s] 1147.2 ± 2.0 1077.0 ± 52.4 1258.5 ± 20.8## 1207.2 ± 41.5# 111.3 ± 27.8 130.2 ± 43.4
CenterTime [s] 462.7 ± 52.5 475.6 ± 67.3 348.2 ± 49.9 341.9 ± 49.9 −114.6 ± 67.9 −133.7 ± 67.8
6–7-month old mice
PerDistance [cm] 2029.8 ± 108.2 2432.5 ± 227.1 1593.5 ± 93.2## 2083.1 ± 205.5* −436.3 ± 132.6 −349.4 ± 214.5
Rearing  [n] 237.0 ± 16.0 259.8 ± 24.9 128.6 ± 9.6### 126.4 ± 16.6### −108.4 ± 19.1 −133.4 ± 21.8
RestTime [s] 1182.5 ± 19.3 1096.6 ± 35.9* 1254.6 ± 19.8## 1188.2 ± 40.1 72.1 ± 24.2 91.6 ± 43.2
CenterTime [s] 480.6 ± 45.6 576.7 ± 67.1 525.2 ± 51.0 481.3 ± 69.6 44.6 ± 36.8 −95.4 ± 72.1
Significant one-way ANOVA effects of ‘restraint stress’ are indicated by ‘#’ (#p < .05, ##p < .01) whereas significant effects of the Nrg1 mutation versus control mice of the
corresponding stress group (baseline or restraint stress) are indicated by asterisks (*p < .05).
Distance ratio and center time were chosen as measures of
anxiety-related behaviours. Acute stress had a significant impact
on distance ratio (p = .01; Fig. 2) and center time (p = .02; Table 1).
Importantly, our analysis revealed hat the ffect of acut  restraint
stress on distance ratio was dependent on the genotype of the
test animals (interaction between ‘restraint stress’ and ‘genotype’:
p = .03) (Fig. 2). Looking at age effects separately, stress decreased
distance ratio in 3–4-month old mice (p = .002) but not in older
m ce (p > .05). A significant interac ion between ‘restraint stress’
Fig. 2. Anxiety-like open field behaviour. Distance ratio [%] is shown in (A) 3–4-
month old mice and (B) 6–7-month old mice at baseline and following acute restraint
stress. Significant one-way ANOVA effects of stress versus baseline of the cor-
responding genotype are indicated by ‘#’ (#p < .05) whereas significant genotype
effects versus WT mice are indicated by asterisks (*p < .05).
and ‘genotype’ was  evident in the 6–7-month old cohort (p = .01):
Nrg1 mutant mice did not exhibit a pronounced anxiety response
to acute restraint stress whereas WT  mice actually showed a
decrease in anxiety behaviour following stress (Fig. 2B). Analysing
! distance ratio revealed a significant ‘genotype’ effect (p = .02;
Fig. 2B). Center time was  significantly reduced by restraint stress
in younger (p = .02) but not older mice (p > .05), although their
stress response was  moderately affected by the genotype (trend
f r inter ction between ‘restraint stress’ and ‘genotype’: p = .07;
Table 1).
3.2. Serum corticosterone
All mice exhibited a significant increase in serum corticosterone
levels in response to restraint stress. Three-way ANOVAs con-
firmed the effect of acute stress on corticosterone levels (p < .001),
which was  evident in both cohorts (3–4 months old: p < .001 – 6–7
months old: p < .001). Nrg1 deficiency had no impact on stress hor-
mone levels (p > .05). However, the level of corticosterone release in
response to stress was genotype-dependent (interaction between
‘restraint stress’ and ‘genotype’: p < .001): in the younger cohort,
stress induced a more pronounced increase in Nrg1 HET mice (10-
fold increase) than in WT  mice (3.5-fold increase), which was
confirmed by a significant interaction between ‘restraint stress’
and ‘genotype’ (p = .02; Fig. 3A) and by analysing ! corticosterone,
which revealed a significant ‘genotype’ effect in the younger cohort
(p = .03; Fig. 3A). No such genotype-dependent effect was  detected
in the older cohort (Fig. 3B).
Interestingly, older mice exhibited generally lower corticos-
terone levels than 3–4-month old mice (p < .001). Importantly,
age also influenced the stress-induced release of corticosterone
as evidenced by an interaction between ‘restraint stress’ and ‘age’
(p < .001). Older mice responded with a less severe increase in
corticosterone than younger mice, which was  confirmed by an
interaction between ‘restraint stress’ and ‘age’ (Nrg1 HET: p < .001;
WT: p = .02).
4. Discussion
This study investigated the behavioural and endocrine response
of a mouse model for Nrg1 to acute restraint stress before and after
the onset of its characteristic hyperlocomotive phenotype. In the
younger mice, acute restraint stress reduced locomotive and explo-
rative measures and increased anxiety-related behaviour in the OF
regardless of genotype. Older Nrg1 mutants did not respond with
increased anxiety to stress. Mice showed robust stress-induced
increases in serum corticosterone regardless of genotype or age.
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 Acute restraint stress had a significant impact on the behavioural performance of 
mice. Stress inhibited locomotive and explorative behaviours and increased resting time. 
Three-way ANOVAs detected an overall effect of stress on total distance travelled (p < .001), 
distance travelled in the periphery (p < .001), rearing frequency (p < .001), and resting time 
(p = .001) (Fig. 1 and Table 1). This impact of stress on OF behaviour was evident in both test 
cohorts: mice at the age of 3–4 months showed a significant stress response in total and 
peripheral distance travelled (both p < .001), frequency of rearing (p = .002) and resting time 
(p < .001) (Fig. 1A and Table 1). Similarly, mice in the 6–7 month old test group exhibited 
stress-induced changes to distance travelled (p = .003), distance travelled in the periphery 
(p = .003), frequency of rearing (p < .001), and resting time (p = .004) (Fig. 1B and Table 1). 
            Distance ratio and center time were chosen as measures of anxiety-related 
behaviours. Acute stress had a significant impact on distance ratio (p = .01; Fig. 2) and center 
time (p = .02; Table 1). Importantly, our analysis revealed that the effect of acute restraint 
stress on distance ratio was dependent on the genotype of the test animals (interaction 
between ‘restraint stress’ and ‘genotype’: p = .03) (Fig. 2). Looking at age effects separately, 
stress decreased distance ratio in 3–4-month old mice (p = .002) but not in older mice 
(p > .05). A significant interaction between ‘restraint stress’ and ‘genotype’ was evident in the 
6–7-month old cohort (p = .01): Nrg1 mutant mice did not exhibit a pronounced anxiety 
response to acute restraint stress whereas WT mice actually showed a decrease in anxiety 
behaviour following stress ( Fig. 2B). Analysing Δ distance ratio revealed a significant 
‘genotype’ effect (p = .02; Fig. 2B). Center time was significantly reduced by restraint stress in 
younger (p = .02) but not older mice (p > .05), although their stress response was moderately 
affected by the genotype (trend for interaction between ‘restraint stress’ and ‘genotype’: 
p = .07; Table 1). 
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Table 1
Effect of restraint stress on open field behaviours in Nrg1 HET and WT mice. Data for distance travelled in periphery (PerDistance), rearing frequency, time spent resting (i.e.
RestTime), and time in the center of the OF (CenterTime) are presented as means ± SEM.
Baseline Restraint stress ! (Restraint − Baseline)
WT  Nrg1 HET WT  Nrg1 HET WT Nrg1 HET
3–4-month old mice
PerDistance [cm] 2264.4 ± 133.7 2808.7 ± 279.4 1825.2 ± 114.9## 2320.1 ± 292.1# −439.2 ± 130.6 −488.6 ± 175.0
Rearing  [n] 218.8 ± 23.1 303.6 ± 52.9 174.9 ± 19.2 215.0 ± 25.2# −43.9 ± 21.0 −88.6 ± 32.6
RestTime [s] 1147.2 ± 2.0 1077.0 ± 52.4 1258.5 ± 20.8## 1207.2 ± 41.5# 111.3 ± 27.8 130.2 ± 43.4
CenterTime [s] 462.7 ± 52.5 475.6 ± 67.3 348.2 ± 49.9 341.9 ± 49.9 −114.6 ± 67.9 −133.7 ± 67.8
6–7-month old mice
PerDistance [cm] 2029.8 ± 108.2 2432.5 ± 227.1 1593.5 ± 93.2## 2083.1 ± 205.5* −436.3 ± 132.6 −349.4 ± 214.5
Rearing  [n] 237.0 ± 16.0 259.8 ± 24.9 128.6 ± 9.6### 126.4 ± 16.6### −108.4 ± 19.1 −133.4 ± 21.8
RestTime [s] 1182.5 ± 19.3 1096.6 ± 35.9* 1254.6 ± 19.8## 1188.2 ± 40.1 72.1 ± 24.2 91.6 ± 43.2
CenterTime [s] 480.6 ± 45.6 576.7 ± 67.1 525.2 ± 51.0 481.3 ± 69.6 44.6 ± 36.8 −95.4 ± 72.1
Signific nt one-way ANOVA effects of ‘restraint stress’ are indicated by ‘#’ (#p < .05, ##p < .01) whereas significant effects of the Nrg1 mutation versus control mice of the
corresponding stress group (baseline or restraint stress) are indicated by asterisks (*p < .05).
Distance ratio and center time were chosen as measures of
anxiety-related behaviours. Acute stress had a significant impact
on distance ratio (p = .01; Fig. 2) and center time (p = .02; Table 1).
Importantly, our analysis revealed that the effect of acute restraint
stress on distance ratio was dependent on the genotype of the
test animals (interaction between ‘restrain  stres ’ and ‘genotype’:
p = .03) (Fig. 2). Looking at age effects separately, stre s decreased
distance ratio in 3–4-month old mice (p = .002) but not in older
mice (p > .05). A significant interaction between ‘restraint stress’
Fig. 2. Anxiety-like open field behaviour. Distance ratio [%] is shown in (A) 3–4-
month old mice and (B) 6–7-month old mice at baseline and following acute restraint
stress. Significant one-way ANOVA effects of stress versus baseline of the cor-
responding genotype are indicated by ‘#’ (#p < .05) whereas significant genotype
effects versus WT mice are indicated by asterisks (*p < .05).
and ‘genotype’ was  evident in the 6–7-month old cohort (p = .01):
Nrg1 mutant mice did not exhibit a pronounced anxiety response
to acute restraint stress whereas WT mice actually showed a
decrease in anxiety behaviour following stress (Fig. 2B). Analysing
! distance ratio revealed a significant ‘genotype’ effect (p = .02;
Fig. 2B). Center time was  significantly reduced by restraint stress
i  younger (p = .02) but not older mice (p > .05), although their
stress response was  moderately affected by the genotype (trend
for interaction between ‘restraint stress’ and ‘genotype’: p = .07;
Table 1).
3.2. Serum corticosterone
All mice exhibited a significant increase in serum corticosterone
levels in response to restraint stress. Three-way ANOVAs con-
firmed the effect of acute stress on corticosterone levels (p < .001),
which was  evident in both cohorts (3–4 months old: p < .001 – 6–7
months old: p < .001). Nrg1 deficiency had no impact on stress hor-
mone levels (p > .05). However, the level of corticosterone release in
response to stress was genotype-dependent (interaction between
‘restraint stress’ and ‘genotype’: p < .001): in the younger cohort,
stress induced a more pronounced increase in Nrg1 HET mice (10-
fold increase) than in WT mice (3.5-fold increase), which was
confirmed by a significant interaction between ‘restraint stress’
and ‘genotype’ (p = .02; Fig. 3A) and by analysing ! corticosterone,
which revealed a significant ‘genotype’ effect in the younger cohort
(p = .03; Fig. 3A). No such genotype-dependent effect was  detected
in the older cohort (Fig. 3B).
Interestingly, older mice exhibited generally lower corticos-
terone levels than 3–4-month old mice (p < .001). Importantly,
age also influenced the stress-induced release of corticosterone
as evidenced by an interaction between ‘restraint stress’ and ‘age’
(p < .001). Older mice responded with a less severe increase in
corticosterone than younger mice, which was  confirmed by an
interaction between ‘restraint stress’ and ‘age’ (Nrg1 HET: p < .001;
WT: p = .02).
4. Discussion
This study investigated the behavioural and endocrine response
of a mouse model for Nrg1 to acute restraint stress before and after
the onset of its characteristic hyperlocomotive phenotype. In the
younger mice, acute restraint stress reduced locomotive and explo-
rative measures and increased anxiety-related behaviour in the OF
regardless of genotype. Older Nrg1 mutants did not respond with
increased anxiety to stress. Mice showed robust stress-induced
increases in serum corticosterone regardless of genotype or age.
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3.2. Serum corticosterone 
All mice exhibited a significant increase in serum corticosterone levels in response to restraint 
stress. Three-way ANOVAs confirmed the effect of acute stress on corticosterone levels 
(p < .001), which was evident in both cohorts (3–4 months old: p < .001 – 6–7 months old: 
p < .001). Nrg1 deficiency had no impact on stress hormone levels (p > .05). However, the 
level of corticosterone release in response to stress was genotype-dependent (interaction 
between ‘restraint stress’ and ‘genotype’: p < .001): in the younger cohort, stress induced a 
more pronounced increase in Nrg1 HET mice (10-fold increase) than in WT mice (3.5-fold 
increase), which was confirmed by a significant interaction between ‘restraint stress’ and 
‘genotype’ (p = .02; Fig. 3A) and by analysing Δ corticosterone, which revealed a significant 
‘genotype’ effect in the younger cohort (p = .03; Fig. 3A). No such genotype-dependent effect 
was detected in the older cohort (Fig. 3B). 
 
	  	   	  
 Interestingly, older mice exhibited generally lower corticosterone levels than 3–4-
month old mice (p < .001). Importantly, age also influenced the stress-induced release of 
corticosterone as evidenced by an interaction between ‘restraint stress’ and ‘age’ (p < .001). 
Older mice responded with a less severe increase in corticosterone than younger mice, which 
was confirmed by an interaction between ‘restraint stress’ and ‘age’ (Nrg1 HET: p < .001; WT: 
p = .02). 
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Fig. 3. Serum corticosterone. Serum corticosterone levels [ng/ml] measured at base-
line and following restraint stress are shown in (A) 3–4-month old mice and (B)
6–7-month old mice. Significant one-way ANOVA effects of stress versus baseline of
the corresponding genotype are indicated by ‘#’ (##p < .01 and ###p < .001) whereas
significant genotype effects versus WT mice are indicated by asterisks (*p < .05).
However, the increase in corticosterone was more pronounced in
Nrg1 mutants than WT mice at 3–4 months of age.
Nrg1 mutant mice exhibit a hyperactive phenotype by the age
of 6–7 months as has been described previously (e.g. [15,32]). In
our study, hyperlocomotion was accompanied by decreased resting
behaviour in baseline co ditions and increased distance travelled
in the periphery post restraint stress.
We hypothesize that mutated Nrg1, once it becomes “active”,
interferes with how the organism responds to environmen-
tal manipulations, as was suggested by earlier research [15].
Indeed, hyperactive Nrg1 HETs (6–7 months old) exhibited no
stress-induced changes in open field anxiety. However, their
endocrine susceptibility to restraint stress was similar to WT
mice. Interestingly, younger mutants exhibited a more pronounced
stress-induced increase in corticosterone than WT mice (2.8-fold)
but showed a WT-like behavioural response to restraint stress. This
might suggest the specificity of age-dependent effects of mutated
Nrg1 on behavioural domains. The fact that this endocrine phe-
notype of younger mutants is missing in older Nrg1 hypomorphs
demands further investigation. Our finding of an apparently dis-
connected endocrine and behavioural stress response in Nrg1
mutant mice was unexpected but is consistent with other mouse
models [19,31].  This phenomenon could be related to an involve-
ment of Nrg1 in stress reactivity downstream from the release of
glucocorticoids. Nrg1 might impact on the expression of gluco-
corticoid receptors or the release of corticotrophin-releasing or
adrenocorticotropin hormone, as has been shown in a rat model
for Type II Nrg1 [29]. Taken together, these findings suggest that
transmembrane domain Nrg1 impacts on the behavioural stress
responses independently of its involvement in the activation of the
glucocorticoid system.
The observation that older WT  mice exhibited decreased
anxiety-like behaviour as a response to stress was surprising, in
particular as these mice showed a stress-related response in other
behavioural and endocrine measures. A similar phenomenon has
been described in another mouse study [2].  Elevated exploration of
open spaces has been interpreted as a strain-specific more active
stress coping mechanism of C57BL/6J mice [22].
There is a paucity of studies on the behavioural and endocrine
effects of acute stress in mouse models for schizophrenia. A recent
study suggested the involvement of Nrg1 in the neuro-endocrine
response of Nrg1 transgenic rats to acute stress [29]. Rats with
reduced levels of Type II Nrg1 displayed sex-specific increased
basal corticosterone levels but a similar peak endocrine response
to restraint stress as non-transgenic animals [28]. The transgenic
rats also exhibited changes in glucocorticoid receptor expression.
The difference in the endocrine stress response between this and
our study (apart from species differences [1])  is probably due to
the particular stress designs used (i.e. rats were exposed to 30 min
of restraint stress after an extended habituation period) and the
characteristics of the Nrg1 modification (i.e. the rat model targets
the 5′ end of the Nrg1 gene, whereas our model targets the 3′
end). Interestingly, in a mouse model for Type III Nrg1, a blunted
increase in corticosterone release in response to mild acute stress-
ors was found in mutant mice [5]. Conflicting findings between
different Nrg1 mouse models are in line with the observation that
the behavioural impact of Nrg1 mutations in mice is highly specific
[14].
Although not specific to mutations in NRG1, it is interesting
to note that non-medicated first episode psychosis patients show
impaired cortisol and hypothalamic-pituitary-adrenal (HPA) axis
activity in stressful situations [33], confirming that it is important
to investigate the link between schizophrenia and stress in more
detail.
Our results suggest that transmembrane domain Nrg1 has only a
minor effect on the behavioural response of mice to acute restraint
stress and only once the Nrg1 mutation has become ‘behaviourally
active’. It is important to note that those behavioural differences
were evident without accompanying modifications to the gluco-
corticoid system. The endocrine response to stress was increased
in Nrg1 mutant mice but only prior to the onset of hyperlocomo-
tion. This suggests that the behavioural differences observed are
not related to endocrine effects. Future research should address the
impact of chronic stress on Nrg1 mutant mice before and after the
development of hyperlocomotion thereby also considering addi-
tional aspects of HPA functions.
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4. Discussion 
 
This study investigated the behavioural and endocrine response of a mouse model for Nrg1 
to acute restraint stress before and after the onset of its characteristic hyperlocomotive 
phenotype. In the younger mice, acute restraint stress reduced locomotive and explorative 
measures and increased anxiety-related behaviour in the OF regardless of genotype. Older 
Nrg1 mutants did not respond with increased anxiety to stress. Mice showed robust stress-
induced increases in serum corticosterone regardless of genotype or age. However, the 
increase in corticosterone was more pronounced in Nrg1 mutants than WT mice at 3–4 
months of age. 
 Nrg1 mutant mice exhibit a hyperactive phenotype by the age of 6–7 months as has 
been described previously (e.g. [15] and [32]). In our study, hyperlocomotion was 
accompanied by decreased resting behaviour in baseline conditions and increased distance 
travelled in the periphery post restraint stress. 
 We hypothesize that mutated Nrg1, once it becomes “active”, interferes with how the 
organism responds to environmental manipulations, as was suggested by earlier research 
[15]. Indeed, hyperactive Nrg1 HETs (6–7 months old) exhibited no stress-induced changes 
in open field anxiety. However, their endocrine susceptibility to restraint stress was similar to 
WT mice. Interestingly, younger mutants exhibited a more pronounced stress-induced 
increase in corticosterone than WT mice (2.8-fold) but showed a WT-like behavioural 
response to restraint stress. This might suggest the specificity of age-dependent effects of 
mutated Nrg1 on behavioural domains. The fact that this endocrine phenotype of younger 
mutants is missing in older Nrg1 hypomorphs demands further investigation. Our finding of an 
apparently disconnected endocrine and behavioural stress response in Nrg1 mutant mice 
was unexpected but is consistent with other mouse models [19] and [31]. This phenomenon 
could be related to an involvement of Nrg1 in stress reactivity downstream from the release of 
glucocorticoids. Nrg1 might impact on the expression of glucocorticoid receptors or the 
release of corticotrophin-releasing or adrenocorticotropin hormone, as has been shown in a 
rat model for Type II Nrg1 [29]. Taken together, these findings suggest that transmembrane 
domain Nrg1 impacts on the behavioural stress responses independently of its involvement in 
the activation of the glucocorticoid system. 
 The observation that older WT mice exhibited decreased anxiety-like behaviour as a 
response to stress was surprising, in particular as these mice showed a stress-related 
response in other behavioural and endocrine measures. A similar phenomenon has been 
described in another mouse study [2]. Elevated exploration of open spaces has been 
interpreted as a strain-specific more active stress coping mechanism of C57BL/6J mice [22]. 
 There is a paucity of studies on the behavioural and endocrine effects of acute stress 
in mouse models for schizophrenia. A recent study suggested the involvement of Nrg1 in the 
neuro-endocrine response of Nrg1 transgenic rats to acute stress [29]. Rats with reduced 
levels of Type II Nrg1 displayed sex-specific increased basal corticosterone levels but a 
similar peak endocrine response to restraint stress as non-transgenic animals [28]. The 
transgenic rats also exhibited changes in glucocorticoid receptor expression. The difference 
in the endocrine stress response between this and our study (apart from species differences 
[1]) is probably due to the particular stress designs used (i.e. rats were exposed to 30 min of 
restraint stress after an extended habituation period) and the characteristics of the Nrg1 
modification (i.e. the rat model targets the 5′ end of the Nrg1 gene, whereas our model targets 
the 3′ end). Interestingly, in a mouse model for Type III Nrg1, a blunted increase in 
corticosterone release in response to mild acute stressors was found in mutant mice [5]. 
Conflicting findings between different Nrg1 mouse models are in line with the observation that 
the behavioural impact of Nrg1 mutations in mice is highly specific [14]. 
 Although not specific to mutations in NRG1, it is interesting to note that non-
medicated first episode psychosis patients show impaired cortisol and hypothalamic-pituitary-
adrenal (HPA) axis activity in stressful situations [33], confirming that it is important to 
investigate the link between schizophrenia and stress in more detail. 
 Our results suggest that transmembrane domain Nrg1 has only a minor effect on the 
behavioural response of mice to acute restraint stress and only once the Nrg1 mutation has 
become ‘behaviourally active’. It is important to note that those behavioural differences were 
evident without accompanying modifications to the glucocorticoid system. The endocrine 
response to stress was increased in Nrg1 mutant mice but only prior to the onset of 
hyperlocomotion. This suggests that the behavioural differences observed are not related to 
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endocrine effects. Future research should address the impact of chronic stress on Nrg1 
mutant mice before and after the development of hyperlocomotion thereby also considering 
additional aspects of HPA functions. 
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